• Je něco špatně v tomto záznamu ?

Endogenous Heparinoids May Cause Bleeding in Mucor Infection and can be Detected by Nonactivated Thromboelastometry and Treated by Recombinant Activated Factor VII: A Case Report

M. Durila, P. Pavlicek, I. Hadacova, J. Nahlovsky, D. Janeckova,

. 2016 ; 95 (8) : e2933.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16027612

Mucormycosis is an aggressive fungal infection, which invades endothelial cells of blood vessels. This condition might lead to destruction of endothelium and release of heparin-like substances to the bloodstream and cause life-threatening bleeding, which is not well described in the literature.We present a patient with mucormycosis who experienced life-threatening bleeding, although no standard laboratory test could detect any coagulopathy.The cause of bleeding-coagulopathy was detected only by nonactivated thromboelastometry (NATEM), which revealed the presence of heparin-like substances. After treatment with recombinant activated FVII rotational thromboelastometry, results improved and the patient stopped bleeding. Regular application of the drug was necessary during acute phase of infection to prevent further bleeding.In this case report, we show that NATEM can detect the presence of heparin-like substances in bleeding patient with mucormycosis infection and that recombinant activated FVII can be used to stop and prevent bleeding until infection resolves.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16027612
003      
CZ-PrNML
005      
20180605100415.0
007      
ta
008      
161005s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/MD.0000000000002933 $2 doi
024    7_
$a 10.1097/MD.0000000000002933 $2 doi
035    __
$a (PubMed)26937941
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Durila, Miroslav $u From the Department of Anesthesiology and Intensive Care Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol (MD, PP), Department of Clinical Haematology, Motol University Hospital (IH), Department of Paedriatric Surgery (JN), and Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic (DJ). $7 xx0224991
245    10
$a Endogenous Heparinoids May Cause Bleeding in Mucor Infection and can be Detected by Nonactivated Thromboelastometry and Treated by Recombinant Activated Factor VII: A Case Report / $c M. Durila, P. Pavlicek, I. Hadacova, J. Nahlovsky, D. Janeckova,
520    9_
$a Mucormycosis is an aggressive fungal infection, which invades endothelial cells of blood vessels. This condition might lead to destruction of endothelium and release of heparin-like substances to the bloodstream and cause life-threatening bleeding, which is not well described in the literature.We present a patient with mucormycosis who experienced life-threatening bleeding, although no standard laboratory test could detect any coagulopathy.The cause of bleeding-coagulopathy was detected only by nonactivated thromboelastometry (NATEM), which revealed the presence of heparin-like substances. After treatment with recombinant activated FVII rotational thromboelastometry, results improved and the patient stopped bleeding. Regular application of the drug was necessary during acute phase of infection to prevent further bleeding.In this case report, we show that NATEM can detect the presence of heparin-like substances in bleeding patient with mucormycosis infection and that recombinant activated FVII can be used to stop and prevent bleeding until infection resolves.
650    _2
$a antifungální látky $x terapeutické užití $7 D000935
650    12
$a vyšetření krevní srážlivosti $7 D001780
650    _2
$a dítě $7 D002648
650    _2
$a drenáž $x škodlivé účinky $7 D004322
650    _2
$a faktor VIIa $x terapeutické užití $7 D015942
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a krvácení $x etiologie $x terapie $7 D006470
650    _2
$a heparinoid $x metabolismus $7 D006496
650    _2
$a lidé $7 D006801
650    _2
$a iatrogenní nemoci $7 D007049
650    _2
$a mukormykóza $x farmakoterapie $x metabolismus $7 D009091
650    _2
$a rekombinantní proteiny $x terapeutické užití $7 D011994
650    _2
$a slezina $x zranění $x chirurgie $7 D013154
650    _2
$a splenektomie $7 D013156
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pavlicek, Petr
700    1_
$a Hadacova, Ivana
700    1_
$a Nahlovsky, Jiri
700    1_
$a Janeckova, Daniela
773    0_
$w MED00012436 $t Medicine $x 1536-5964 $g Roč. 95, č. 8 (2016), s. e2933
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26937941 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20180605100617 $b ABA008
999    __
$a ok $b bmc $g 1165926 $s 952242
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 95 $c 8 $d e2933 $i 1536-5964 $m Medicine $n Medicine $x MED00012436
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...